Contribution of Peripheral Vision in the Risk of Falls in the Elderly

May 20, 2026 updated by: University Hospital, Lille

This study is a controlled, open-label biomedical research project in cognitive neuroscience designed to examine the results (postural stability, error rates, and spatiotemporal parameters of eye movements and head movements) of three tests assessing visuospatial functions (active object search, simple exploration, and a control condition with fixation on a stationary point) in two groups of subjects:

  • a group of patients with a history of falls
  • a control group of patients matched for age (±5 years) and sex who had not fallen recently.

Study Overview

Status

Withdrawn

Conditions

Study Type

Observational

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

The study will be conducted on two groups of patients over the age of 70: one group with a history of one or more falls within the past year, and the other group with no history of falls during that same period. The two groups will be matched for age (±5 years) and gender.

Description

Inclusion Criteria:

  • men or women
  • who have fallen one or more times in the past 12 months
  • aged 70 or older
  • independent in activities of daily living (ADL ≥ 5.5/6, with occasional urinary incontinence)
  • who speak French
  • who are covered by Social Security
  • who have provided informed consent and signed the consent form

Exclusion Criteria:

  • who have not fallen in the past year
  • aged 70 or older
  • independent in activities of daily living (ADL = 6/6)
  • French-speaking
  • covered by Social Security
  • who have provided informed consent and signed the consent form

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
peripheral vision
Time Frame: characterize postural instability based on the difficulty of the visual task at baseline.
Maximum range of mediolateral head movement under different visual conditions.
characterize postural instability based on the difficulty of the visual task at baseline.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: François Puisieux, MD, PhD, University Hospital, Lille

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 1, 2015

Primary Completion (Actual)

November 1, 2017

Study Completion (Actual)

November 1, 2019

Study Registration Dates

First Submitted

May 14, 2026

First Submitted That Met QC Criteria

May 20, 2026

First Posted (Actual)

May 27, 2026

Study Record Updates

Last Update Posted (Actual)

May 27, 2026

Last Update Submitted That Met QC Criteria

May 20, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 2013_52
  • 2014-A00502-45 (Other Identifier: ID-RCB number, ANSM)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Fall

3
Subscribe